DOI:
10.1055/s-00000111
ZFA - Zeitschrift für Allgemeinmedizin
LinksClose Window
References
Curtis SP, Bockow B, Fisher C. et al.
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
BMC Musculoskelet Disord 2005; 6: 58-
We do not assume any responsibility for the contents of the web pages of other providers.